Company Filing History:
1 out of 75 
1 out of 1 
1 out of 5 Years Active: 2017
Title: Michael Roden: Innovator in Diabetes Research
Introduction
Michael Roden is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes mellitus. His innovative work aims to improve the understanding and prevention of this prevalent condition.
Latest Patents
Michael Roden holds a patent for a method of identifying a predisposition for developing type 2 diabetes mellitus. This invention involves assessing specific metabolites in a sample obtained from a subject. The method focuses on measuring the amounts of certain metabolites, including glycine and various lysoPhosphatidylcholines, to determine the risk of developing the disease. Additionally, the patent outlines a method for identifying compounds that can prevent type 2 diabetes and related diseases, as well as a kit for this purpose.
Career Highlights
Throughout his career, Michael Roden has worked with esteemed organizations such as the Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt and the Deutsche Diabetes-Forschungsgesellschaft e.V., which is the sponsor of the German Diabetes Center in Düsseldorf. His research has significantly advanced the understanding of diabetes and its prevention.
Collaborations
Michael has collaborated with notable colleagues, including Wolfgang Rathmann and Christian Herder. These partnerships have further enriched his research and contributed to the development of innovative solutions in diabetes care.
Conclusion
Michael Roden's work in diabetes research exemplifies the impact of innovation in healthcare. His patented methods and collaborations continue to pave the way for advancements in the prevention and understanding of type 2 diabetes mellitus.